Spire Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Buy
59
+9
+18% +$1.94K ﹤0.01% 1537
2026
Q1
$10K Buy
+50
New +$10.3K ﹤0.01% 1608
2025
Q3
Sell
-31
Closed -$5K 2395
2025
Q2
$5K Sell
31
-50
-62% -$7.96K ﹤0.01% 1946
2025
Q1
$13.8K Buy
81
+50
+161% +$8.68K ﹤0.01% 1733
2024
Q4
$5.15K Sell
31
-225
-88% -$38.4K ﹤0.01% 2037
2024
Q3
$44K Buy
256
+225
+726% +$37.2K ﹤0.01% 1170
2024
Q2
$4.77K Buy
+31
New +$4.65K ﹤0.01% 1836
2024
Q1
Sell
-259
Closed -$39.3K 2337
2023
Q4
$39.3K Hold
259
﹤0.01% 1288
2023
Q3
$37.9K Sell
259
-2,707
-91% -$412K ﹤0.01% 1269
2023
Q2
$454K Sell
2,966
-3,466
-54% -$540K 0.02% 515
2023
Q1
$997K Buy
6,432
+6,277
+4,050% +$986K 0.04% 342
2022
Q4
$24K Sell
155
-3,842
-96% -$567K ﹤0.01% 1297
2022
Q3
$528K Sell
3,997
-3,054
-43% -$429K 0.03% 321
2022
Q2
$956K Buy
7,051
+6,465
+1,103% +$891K 0.04% 337
2022
Q1
$87K Sell
586
-7,093
-92% -$1.05M ﹤0.01% 1213
2021
Q4
$1.24M Buy
7,679
+6,466
+533% +$1.05M 0.03% 408
2021
Q3
$201K Buy
1,213
+81
+7% +$13.8K 0.01% 921
2021
Q2
$195K Sell
1,132
-7,988
-88% -$1.32M 0.01% 951
2021
Q1
$1.46M Buy
+9,120
New +$1.56M 0.04% 348

Other funds holding FBT

Spire Wealth Management's FBT Position: Q2 2026 in Review

Spire Wealth Management increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 18% in Q2 2026, buying an estimated $1.94K and bringing the position to 59 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

Spire Wealth Management first reported a position in FBT in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.46M in Q1 2021. 64 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Spire Wealth Management held 59 shares of First Trust NYSE Arca Biotechnology Index Fund worth $14.6K as of Q2 2026.
  • Spire Wealth Management bought 9 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.94K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1537 holding.
  • Spire Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and has held it in 19 quarters since.
  • Spire Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.46M in Q1 2021.
  • 64 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.